Published on 5 Feb 2024 on Simply Wall St. via Yahoo Finance
It is hard to get excited after looking at Maravai LifeSciences Holdings' (NASDAQ:MRVI) recent performance, when its stock has declined 24% over the past three months. But if you pay close attention, you might find that its key financial indicators look quite decent, which could mean that the stock could potentially rise in the long-term given how markets usually reward more resilient long-term fundamentals. In this article, we decided to focus on Maravai LifeSciences Holdings' ROE.
ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders.
See our latest analysis for Maravai LifeSciences Holdings